MedTrace Logo

Community Support Program for Lung Cancer Screening

NCT06207435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 242

Last updated 2025-09-02

Study results available
· View outcomes & findings →

Summary

The research study aims to create a program for lung cancer screening attendance

Conditions

Interventions

BEHAVIORAL

Transportation

Eligible patients are contacted and offered free transportation to and from their upcoming appointment.

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Farouk Dako, MD, MPH · University of Pennsylvania

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-10
Primary Completion
2024-08-12
Completion
2024-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06207435 on ClinicalTrials.gov